ReviewTranslational lung cancer research2022

The treatment of advanced non-small cell lung cancer harboring KRAS mutation: a new class of drugs for an old target-a narrative review.

Alessia Spagnuolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.